These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


157 related items for PubMed ID: 10753973

  • 1. Reversible phosphorylation at the C-terminal regulatory domain of p21(Waf1/Cip1) modulates proliferating cell nuclear antigen binding.
    Scott MT, Morrice N, Ball KL.
    J Biol Chem; 2000 Apr 14; 275(15):11529-37. PubMed ID: 10753973
    [Abstract] [Full Text] [Related]

  • 2. AKT/PKB phosphorylation of p21Cip/WAF1 enhances protein stability of p21Cip/WAF1 and promotes cell survival.
    Li Y, Dowbenko D, Lasky LA.
    J Biol Chem; 2002 Mar 29; 277(13):11352-61. PubMed ID: 11756412
    [Abstract] [Full Text] [Related]

  • 3. Growth inhibition by CDK-cyclin and PCNA binding domains of p21 occurs by distinct mechanisms and is regulated by ubiquitin-proteasome pathway.
    Rousseau D, Cannella D, Boulaire J, Fitzgerald P, Fotedar A, Fotedar R.
    Oncogene; 1999 May 27; 18(21):3290-302. PubMed ID: 10359535
    [Abstract] [Full Text] [Related]

  • 4. Characterization of p21Cip1/Waf1 peptide domains required for cyclin E/Cdk2 and PCNA interaction.
    Chen IT, Akamatsu M, Smith ML, Lung FD, Duba D, Roller PP, Fornace AJ, O'Connor PM.
    Oncogene; 1996 Feb 01; 12(3):595-607. PubMed ID: 8637717
    [Abstract] [Full Text] [Related]

  • 5. The permissive effect of p21(Waf1/Cip1) on DNA synthesis is dependent on cell type: effect is absent in p53-inactive cells.
    Weiss RH, Randour CJ.
    Cell Signal; 2000 Jun 01; 12(6):413-8. PubMed ID: 10889470
    [Abstract] [Full Text] [Related]

  • 6. TOK-1, a novel p21Cip1-binding protein that cooperatively enhances p21-dependent inhibitory activity toward CDK2 kinase.
    Ono T, Kitaura H, Ugai H, Murata T, Yokoyama KK, Iguchi-Ariga SM, Ariga H.
    J Biol Chem; 2000 Oct 06; 275(40):31145-54. PubMed ID: 10878006
    [Abstract] [Full Text] [Related]

  • 7. Growth inhibition by CDK-cyclin and PCNA binding domains of p21 occurs by distinct mechanisms and is regulated by ubiquitin-proteasome pathway.
    Rousseau D, Cannella D, Boulaire J, Fitzgerald P, Fotedar A, Fotedar R.
    Oncogene; 1999 Jul 29; 18(30):4313-25. PubMed ID: 10439039
    [Abstract] [Full Text] [Related]

  • 8. Deregulation of p53/p21Cip1/Waf1 pathway contributes to polyploidy and apoptosis of E1A+cHa-ras transformed cells after gamma-irradiation.
    Bulavin DV, Tararova ND, Aksenov ND, Pospelov VA, Pospelova TV.
    Oncogene; 1999 Oct 07; 18(41):5611-9. PubMed ID: 10523840
    [Abstract] [Full Text] [Related]

  • 9. Mediation of proliferating cell nuclear antigen (PCNA)-dependent DNA replication through a conserved p21(Cip1)-like PCNA-binding motif present in the third subunit of human DNA polymerase delta.
    Ducoux M, Urbach S, Baldacci G, Hübscher U, Koundrioukoff S, Christensen J, Hughes P.
    J Biol Chem; 2001 Dec 28; 276(52):49258-66. PubMed ID: 11595739
    [Abstract] [Full Text] [Related]

  • 10. Immortalization of human fibroblasts by SV40 large T antigen results in the reduction of cyclin D1 expression and subunit association with proliferating cell nuclear antigen and Waf1.
    Peterson SR, Gadbois DM, Bradbury EM, Kraemer PM.
    Cancer Res; 1995 Oct 15; 55(20):4651-7. PubMed ID: 7553644
    [Abstract] [Full Text] [Related]

  • 11. Yin Yang-1 inhibits vascular smooth muscle cell growth and intimal thickening by repressing p21WAF1/Cip1 transcription and p21WAF1/Cip1-Cdk4-cyclin D1 assembly.
    Santiago FS, Ishii H, Shafi S, Khurana R, Kanellakis P, Bhindi R, Ramirez MJ, Bobik A, Martin JF, Chesterman CN, Zachary IC, Khachigian LM.
    Circ Res; 2007 Jul 20; 101(2):146-55. PubMed ID: 17556661
    [Abstract] [Full Text] [Related]

  • 12. The C-terminal region of p21SDI1/WAF1/CIP1 is involved in proliferating cell nuclear antigen binding but does not appear to be required for growth inhibition.
    Nakanishi M, Robetorye RS, Pereira-Smith OM, Smith JR.
    J Biol Chem; 1995 Jul 21; 270(29):17060-3. PubMed ID: 7615495
    [Abstract] [Full Text] [Related]

  • 13. A quantitative study of the in vitro binding of the C-terminal domain of p21 to PCNA: affinity, stoichiometry, and thermodynamics.
    Zheleva DI, Zhelev NZ, Fischer PM, Duff SV, Warbrick E, Blake DG, Lane DP.
    Biochemistry; 2000 Jun 27; 39(25):7388-97. PubMed ID: 10858286
    [Abstract] [Full Text] [Related]

  • 14. Status of p53 phosphorylation and function in sensitive and resistant human cancer models exposed to platinum-based DNA damaging agents.
    Mujoo K, Watanabe M, Nakamura J, Khokhar AR, Siddik ZH.
    J Cancer Res Clin Oncol; 2003 Dec 27; 129(12):709-18. PubMed ID: 14513366
    [Abstract] [Full Text] [Related]

  • 15. Interaction with cyclin-dependent kinases and PCNA modulates proteasome-dependent degradation of p21.
    Cayrol C, Ducommun B.
    Oncogene; 1998 Nov 12; 17(19):2437-44. PubMed ID: 9824154
    [Abstract] [Full Text] [Related]

  • 16. Phage-peptide display identifies the interferon-responsive, death-activated protein kinase family as a novel modifier of MDM2 and p21WAF1.
    Burch LR, Scott M, Pohler E, Meek D, Hupp T.
    J Mol Biol; 2004 Mar 12; 337(1):115-28. PubMed ID: 15001356
    [Abstract] [Full Text] [Related]

  • 17. Akt-dependent phosphorylation of p21(Cip1) regulates PCNA binding and proliferation of endothelial cells.
    Rössig L, Jadidi AS, Urbich C, Badorff C, Zeiher AM, Dimmeler S.
    Mol Cell Biol; 2001 Aug 12; 21(16):5644-57. PubMed ID: 11463845
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of colon cancer cell proliferation by the dietary compound conjugated linoleic acid is mediated by the CDK inhibitor p21CIP1/WAF1.
    Lim DY, Tyner AL, Park JB, Lee JY, Choi YH, Park JH.
    J Cell Physiol; 2005 Oct 12; 205(1):107-13. PubMed ID: 15880444
    [Abstract] [Full Text] [Related]

  • 19. Cell-cycle inhibition by independent CDK and PCNA binding domains in p21Cip1.
    Luo Y, Hurwitz J, Massagué J.
    Nature; 1995 May 11; 375(6527):159-61. PubMed ID: 7753174
    [Abstract] [Full Text] [Related]

  • 20. Stoichiometry of cyclin A-cyclin-dependent kinase 2 inhibition by p21Cip1/Waf1.
    Adkins JN, Lumb KJ.
    Biochemistry; 2000 Nov 14; 39(45):13925-30. PubMed ID: 11076534
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.